22
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer.

      1 , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,   , , , ,
      JAMA
      American Medical Association (AMA)

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Approximately 10% of women with invasive epithelial ovarian cancer (EOC) carry deleterious germline mutations in BRCA1 or BRCA2. A recent article suggested that BRCA2-related EOC was associated with an improved prognosis, but the effect of BRCA1 remains unclear.

          Related collections

          Author and article information

          Journal
          JAMA
          JAMA
          American Medical Association (AMA)
          1538-3598
          0098-7484
          Jan 25 2012
          : 307
          : 4
          Affiliations
          [1 ] Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.
          Article
          307/4/382 NIHMS449532
          10.1001/jama.2012.20
          3727895
          22274685
          2e5e9f4f-94d6-42ce-ad2e-b1aaf44dff8f
          History

          Comments

          Comment on this article